Solaris Resources Inc. (CVE:SLS – Get Free Report)’s share price dropped 2.7% during trading on Thursday . The company traded as low as C$5.95 and last traded at C$6.15. Approximately 53,313 shares were traded during trading, a decline of 60% from the average daily volume of 132,199 shares. The stock had previously closed at C$6.32.
Solaris Resources Trading Down 2.7 %
The business has a 50-day simple moving average of C$6.15 and a two-hundred day simple moving average of C$6.15.
Solaris Resources Company Profile
SELLAS Life Sciences Group, Inc, a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the treatment of acute myeloid leukemia; and in Phase 1/2 clinical trials for the treatment for ovarian cancer.
Further Reading
- Five stocks we like better than Solaris Resources
- What Makes a Stock a Good Dividend Stock?
- 3 Legacy Tech Companies Reemerging as AI LeadersÂ
- Investing In Preferred Stock vs. Common Stock
- Analysts’ Favorite Cybersecurity Stocks: 3 Top Picks
- Stock Dividend Cuts Happen Are You Ready?
- Analysts Are Bullish: 3 Tech Giants With Upgraded Price Targets
Receive News & Ratings for Solaris Resources Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Solaris Resources and related companies with MarketBeat.com's FREE daily email newsletter.
